R&D channel feed – Endpoints News

R&D channel feed

Otsuka’s cytokine-targeting drug for IgAN clears Phase 3 hurdle

7 months ago

Ahead of Novo’s CagriSema readout, Lilly returns to a promising new class of obesity drugs

7 months ago

Roche, Genentech end anti-tau Alzheimer’s drug collaboration with UCB

7 months ago

Gilead, Merck's experimental long-acting HIV treatment heads to Phase 3

7 months ago

Regenxbio shares new mid-stage data for its wet AMD gene therapy

7 months ago

Nurix says protein degrader shows potential in Waldenstrom’s patients in early trial

7 months ago

Novo declares Phase 3 cardiac outcomes trial win for oral GLP-1

7 months ago

Vertex shares full pivotal non-opioid pain data, showing better safety than placebo

7 months ago

Lykos is optimistic about MDMA treatment after meeting with FDA

7 months ago

A conversation with Nobel Prize winner David Baker on the future of AI in protein design — and beyond

7 months ago

FDA partially holds BioNTech's Phase 3 anti-CTLA-4, company pauses enrollment

7 months ago

Shanghai biotech’s VEGF bispecific enters Phase 1 trial in China

7 months ago

Gilead pulls Trodelvy's accelerated label in bladder cancer after drug failed confirmatory study

7 months ago

Pfizer ends trial of Array-acquired SHP2 inhibitor after similar cuts from peers

7 months ago

Supernus’ depression drug shows ‘rapid’ onset in mid-stage test

7 months ago

Merck unveils RSV antibody data, in bid to compete with AstraZeneca and Sanofi

7 months ago

Amylyx presents full Phase 2 data for withdrawn ALS drug in another rare genetic disease

7 months ago

Sage shakes up senior management, slashes pipeline, sheds 33% of staff

7 months ago

Novartis pays $70M upfront to license Chinese biotech’s antitumor drug

7 months ago

Bavarian Nordic's mpox vaccine was safe and spurred promising immune response in children

7 months ago

First clinical test of RNA editing restores missing protein in genetic disease, Wave says

7 months ago

FDA places hold on Novavax's Covid-flu and standalone influenza vaccines

7 months ago

Q&A: Sanofi’s R&D head reflects on his first year, a post-Dupixent future, and finding an identity

7 months ago

Takeda parts ways with Wave Life Sciences even with Huntington’s trial win

7 months ago

First page Previous page 21 22 232425 26 27 Next page Last page